The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: Implications of continuous dopaminergic stimulation at night to treat the symptoms

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Sleep problems are an under-emphasized cause of disability in Parkinson's disease (PD). Difficult sleep maintenance (light and fragmented sleep) and difficulties in initiating sleep are often the earliest and the most frequent symptoms observed in PD patients. In fluctuating patients, nocturnal akinesia, dystonia, painful cramps, and parasomnias may aggravate nocturnal problems. Treatment of sleep problems can be complex and challenging for the physicians. Dopaminergic treatment may improve some of the nocturnal symptoms in PD. In this paper, the effect of drugs and technique that ensure a more continuous delivery of dopaminergic drugs on sleep problems in PD is reviewed.

Original languageEnglish
JournalJournal of Neural Transmission
Volume121
Issue numberSUPPL. 1
DOIs
Publication statusPublished - 2014

Fingerprint

Parkinson Disease
Sleep
Parasomnias
Muscle Cramp
Dopamine Agents
Dystonia
Maintenance
Physicians
Light
Therapeutics
Pharmaceutical Preparations

Keywords

  • Apomorphine
  • CDS
  • Dopamine agonist
  • Levodopa
  • Parkinson's disease
  • Sleep

ASJC Scopus subject areas

  • Biological Psychiatry
  • Neurology
  • Clinical Neurology
  • Psychiatry and Mental health
  • Medicine(all)

Cite this

@article{c1275e87906c40a38b4a59bc42ed0b3f,
title = "The relevance of dopaminergic level in nocturnal disability in Parkinson's disease: Implications of continuous dopaminergic stimulation at night to treat the symptoms",
abstract = "Sleep problems are an under-emphasized cause of disability in Parkinson's disease (PD). Difficult sleep maintenance (light and fragmented sleep) and difficulties in initiating sleep are often the earliest and the most frequent symptoms observed in PD patients. In fluctuating patients, nocturnal akinesia, dystonia, painful cramps, and parasomnias may aggravate nocturnal problems. Treatment of sleep problems can be complex and challenging for the physicians. Dopaminergic treatment may improve some of the nocturnal symptoms in PD. In this paper, the effect of drugs and technique that ensure a more continuous delivery of dopaminergic drugs on sleep problems in PD is reviewed.",
keywords = "Apomorphine, CDS, Dopamine agonist, Levodopa, Parkinson's disease, Sleep",
author = "Fabrizio Stocchi and Paola Stirpe",
year = "2014",
doi = "10.1007/s00702-014-1259-2",
language = "English",
volume = "121",
journal = "Journal of Neural Transmission",
issn = "0300-9564",
publisher = "Springer-Verlag Wien",
number = "SUPPL. 1",

}

TY - JOUR

T1 - The relevance of dopaminergic level in nocturnal disability in Parkinson's disease

T2 - Implications of continuous dopaminergic stimulation at night to treat the symptoms

AU - Stocchi, Fabrizio

AU - Stirpe, Paola

PY - 2014

Y1 - 2014

N2 - Sleep problems are an under-emphasized cause of disability in Parkinson's disease (PD). Difficult sleep maintenance (light and fragmented sleep) and difficulties in initiating sleep are often the earliest and the most frequent symptoms observed in PD patients. In fluctuating patients, nocturnal akinesia, dystonia, painful cramps, and parasomnias may aggravate nocturnal problems. Treatment of sleep problems can be complex and challenging for the physicians. Dopaminergic treatment may improve some of the nocturnal symptoms in PD. In this paper, the effect of drugs and technique that ensure a more continuous delivery of dopaminergic drugs on sleep problems in PD is reviewed.

AB - Sleep problems are an under-emphasized cause of disability in Parkinson's disease (PD). Difficult sleep maintenance (light and fragmented sleep) and difficulties in initiating sleep are often the earliest and the most frequent symptoms observed in PD patients. In fluctuating patients, nocturnal akinesia, dystonia, painful cramps, and parasomnias may aggravate nocturnal problems. Treatment of sleep problems can be complex and challenging for the physicians. Dopaminergic treatment may improve some of the nocturnal symptoms in PD. In this paper, the effect of drugs and technique that ensure a more continuous delivery of dopaminergic drugs on sleep problems in PD is reviewed.

KW - Apomorphine

KW - CDS

KW - Dopamine agonist

KW - Levodopa

KW - Parkinson's disease

KW - Sleep

UR - http://www.scopus.com/inward/record.url?scp=84905090380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905090380&partnerID=8YFLogxK

U2 - 10.1007/s00702-014-1259-2

DO - 10.1007/s00702-014-1259-2

M3 - Article

C2 - 24990308

AN - SCOPUS:84905090380

VL - 121

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

SN - 0300-9564

IS - SUPPL. 1

ER -